POZEN, INC. ANNOUNCES RECEIPT OF $40 MILLION UPFRONT PAYMENT FROM ASTRAZENECA PL

POZEN Inc., announced the receipt of the $40 million initial upfront payment from AstraZeneca in connection with the exclusive global collaboration agreement between the two companies. The previously announced collaboration with AstraZeneca has cleared the waiting period required under the Hart-Scott-Rodino Anti-trust Improvements Act making the agreement effective.

BioSpace (http://www.biospace.com/news_story.aspx?StoryID=30678&full=1)